CRO Services (Phase I-III) Partners

Clinical Trials are required for drug therapies to receive regulatory approval.

A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest dose of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.

How can we help?

Looking for help with your Phase I-III project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.

Submit A Question

CRO Services Center (Phase I-III) Provider - Altasciences
Altasciences

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

CRO Services Center (Phase I-III) Provider - Biorasi
Biorasi

Biorasi is the Go-To CRO for global clinical trials! For over 20 years, we have been trusted by small to midsized biopharma companies to provide customized solutions for today's clinical research challenges. Biorasi optimizes clinical studies for multiple therapeutic areas, reaching successful results through reliable, flexible, and accessible solutions provided by our #OneTeam of industry experts.

Capabilities

CRO Services Center (Phase I-III) Provider - Catalyst Flex
Catalyst Flex

Catalyst Flex, a functional service provider (FSP) solution of Catalyst Clinical Research, is a multi-therapeutic niche contract research organization (CRO)with flexible, fit-for-purpose offerings in global resourcing, functional services, and hybrid models for partners and clients in clinical operations, biometrics, medical writing, and safety services. We supply people, process, and technology solutions designed to meet each client’s unique functional needs.


Have questions about selecting the right Phase I-III service provider?

The Clinical Leader team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


CRO Services Center (Phase I-III) Provider - CHDR
CHDR

The Centre for Human Drug Research (CHDR) is an independent, full-service contract research organization (CRO) that specializes in cutting-edge, early phase clinical drug research in both healthy volunteers and small patient cohorts, across a wide range of therapeutic areas.

CRO Services Center (Phase I-III) Provider - Ergomed Clinical Research
Ergomed Clinical Research

Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner.

Capabilities

CRO Services Center (Phase I-III) Provider - IQVIA Biotech
IQVIA Biotech

IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.

Capabilities


CRO Services Center (Phase I-III) Provider - IQVIA Safety & Regulatory Compliance
IQVIA Safety & Regulatory Compliance

IQVIA Safety & Regulatory Compliance offers a complete lifecycle approach that brings together safety, regulatory, quality, and medical information to transform how life sciences companies sustain compliance and how compliance functions perform better together.

By integrating services, technology, and analytics, we can help bring together disparate compliance functions, resulting in heightened patient safety, improved compliance performance, and proactive insights power by IQVIA Connected Intelligence.

CRO Services Center (Phase I-III) Provider - Novotech
Novotech

Novotech leverages its therapeutic and regulatory expertise, client-centric service model, local market insights, and advanced analytical tools to expedite patient recruitment, enhance trial efficiencies, and bring life-changing therapies to market faster.

Capabilities

CRO Services Center (Phase I-III) Provider - palleos healthcare
palleos healthcare

palleos healthcare is a central European full-service Clinical Research Organization (CRO) focused on product development including pre-clinical consulting and clinical services for small to large scale trials. More than 10,000 patients in 300 sites have been treated throughout various indications.


CRO Services Center (Phase I-III) Provider - Precision for Medicine
Precision for Medicine

Precision for Medicine is an industry-leading global precision medicine clinical research organization and a leader in complex clinical development. Our clients benefit from advanced technologies and new approaches that compress timelines, gain efficiencies, and increase the probability of approval. Under one global roof, Precision has integrated sophisticated biomarker capabilities and laboratory expertise, worldwide CRO services, data intelligence solutions, and more.

Capabilities

CRO Services Center (Phase I-III) Provider - Quotient Sciences
Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.

Capabilities

CRO Services Center (Phase I-III) Provider - SGS North America, Inc.
SGS North America, Inc.

Specialized bioanalytical testing services to support discovery, pre-clinical and Phase 1 - 3 clinical trials. Backed by 30 years of global pharmaceutical testing expertise, SGS provides a complete range of bioanalytical solutions, including Method development, validation and transfer; PK and PD Bioanalysis, ELISA and multiplex assays, bioassays, Immunogenicity testing, and more.


CRO Services Center (Phase I-III) Provider - Southern Star Research
Southern Star Research

Southern Star Research is a full-service CRO dedicated to navigating the complexities of bringing new medical products to market. With a legacy of excellence that began 14 years ago in Sydney, we have grown from a small, passionate team into a global network of experts committed to delivering high-quality services in medical writing, clinical monitoring, project management, biostatistics, data management, safety and medical monitoring, and quality assurance.

Capabilities

CRO Services Center (Phase I-III) Provider - TFS HealthScience
TFS HealthScience

TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.

Capabilities

CRO Services Center (Phase I-III) Provider - Thermo Fisher Scientific
Thermo Fisher Scientific

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.


CRO Services Center (Phase I-III) Provider - Veristat, Inc.
Veristat, Inc.

Veristat, the Science-First™ full service CRO and consultancy, enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development onto regulatory approval and post-marketing. With our focus on novel drug development and 30 years of experience in clinical trial planning and execution, we deliver bold approaches that make the impossible possible.

Capabilities